Quality Metrics Team

Print this page         

ISPE Quality Metrics Steering Team

  • Michael Arnold, Pfizer Global Clinical Supplies, ISPE Int’l Board
  • Blair Okita, EMD Serono, Inc.
  • John Bournas, ISPE President & CEO
  • Peter Carbone, Novartis Pharmaceuticals
  • Jacqueline Elbonne, Merck & Co., Inc
  • Joseph Famulare, Genentech/Roche, ISPE Int’l Board
  • Katy George, Mckinsey Company Inc
  • Donna Gulbinski, Bristol-Myers Squibb Co
  • Dora Kourti, ISPE Sr VP for Global Regulatory Affairs
  • Robert Matje, ISPE Int’l Board
  • Elizabeth Blackwood, Johnson & Johnson
  • Joseph Devito, Teva

ISPE Quality Metrics Core Team

  • Mairead Goetz, Novartis Pharmaceuticals Corporation, Chair
  • Nuala Calnan, Dublin Institute of Technology
  • Laura Cannon, Teva Pharmaceuticals
  • Michael Davidson, Pfizer
  • Betsy Fritschel, Johnson & Johnson
  • Steve Greer, Procter & Gamble
    Diane Hagerty, Genentech Inc.
  • Lorraine Mcclain, Teva Pharmaceuticals
  • Matthew Pearson, Genentech Inc
  • Paul Rutten, McKinsey & Co
  • Peggy Speight, Bristol-Myers Squibb
  • Vanya Telpis,  McKinsey & Company
  • Paul Weninger, Perrigo Company PLC
  • Bryan Winship, Mylan
  • Christopher Potter, ISPE
  • Carol Winfield, ISPE

 

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile

ISPEAK Logo

An ISPE
Information
Resource

Chairman Chatter: Embracing the Challenge
Tuesday, 20 Sep 2016 19.09

Women in Pharma Debuts at 2016 ISPE Annual Meeting & Expo
Tuesday, 20 Sep 2016 14.09

You’re All HEROES! Two Powerful Pharma Keynote Messages
Tuesday, 20 Sep 2016 02.09